Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +49.94%
#3 Velvet Velvet +41.51%
#4 Black Phoenix Black Phoenix +34.92%
#5 DoubleZero DoubleZero +20.39%
#6 Akedo Akedo +19.80%
#7 Fake World Assets Fake World Assets +19.72%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.14%
#9 HOME HOME +13.87%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.99%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Actavia Life Sciences, Inc. Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc.

RASP
Rank in Stocks #39684
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing... Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Share Price
$0.0005
Last synced: 2026-08-12
Market Cap
$385.91K
Change (1 day)
0.00%
Change (1 year)
-87.50%
Country
US
Trade Actavia Life Sciences, Inc. (RASP)

Category

Healthcare
P/E ratio for Actavia Life Sciences, Inc. (RASP)
P/E ratio as of 2026 TTM: 0
According to Actavia Life Sciences, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Actavia Life Sciences, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 28.05 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 31.14 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 19.30 -
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.